Sanofi

US Department of Health and Human Services calls for coronavirus product proposals

BARDA has also partnered with French drugmaker Sanofi Pasteur’s vaccines division on a project for the novel coronavirus, which will tap into the company’s earlier work on the SARS ... virus. Sanofi’s prior work on SARS – another type of

BMS partners with Voluntis to co-develop oncology digital therapeutics

In 2017, it expanded an alliance with Sanofi to develop a new mobile app for insulin patients. ... Sanofi recently announced it will halt research and development in diabetes to further its focus on other, more key growth areas.

FDA approves Sanofi’s key cancer drug Sarclisa for myeloma

The US Food and Drug Administration (FDA) has approved Sanofi’s cancer treatment Sarclisa for multiple myeloma, bolstering the company’s ambitions in the therapy area. ... New CEO Paul Hudson’s plans to revamp Sanofi’s business are now in full

Doctors worried NHS is unprepared for coronavirus as government unveils action plan

A number of pharma companies are currently undertaking research into possible vaccine candidates, including Sanofi, GlaxoSmithKline, Moderna and Gilead, among others. ... We think there are good tools and approaches at hand that will find success, but we

Can protein degraders unlock ‘undruggable’ drug targets?

It raised $30m in its series A in 2017, and followed that up with a second-round fundraising last November that raised $67m and added Pfizer and Sanofi’s venture capital

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]